Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$837M |
| 3 |
Amazon
AMZN
|
+$811M |
| 4 |
Kenvue
KVUE
|
+$761M |
| 5 |
Blackstone
BX
|
+$581M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$438M |
| 2 |
Texas Instruments
TXN
|
+$235M |
| 3 |
Pfizer
PFE
|
+$205M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.07% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Alico
ALCO
$283M
| $3.14M | ﹤0.01% |
125,695
+784
| +0.6% | +$19.5K |
|
2877
Granite Ridge Resources
GRNT
$611M
| $3.14M | ﹤0.01% |
514,265
+122,247
| +31% | +$853K |
|
|
TBCH
2878
Turtle Beach Corp
TBCH
$269M
| $3.14M | ﹤0.01% |
345,463
+22,562
| +7% | +$242K |
|
|
ONIT
2879
Onity Group
ONIT
$321M
| $3.13M | ﹤0.01% |
120,780
-2,518
| -2% | -$75.5K |
|
2880
Colony Bankcorp
CBAN
$470M
| $3.1M | ﹤0.01% |
310,549
+12,136
| +4% | +$124K |
|
2881
Pearson
PSO
$10B
| $3.1M | ﹤0.01% |
294,486
+15,257
| +5% | +$163K |
|
|
MACK
2882
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $3.1M | ﹤0.01% |
251,585
+7,783
| +3% | +$94.2K |
|
2883
Monte Rosa Therapeutics
GLUE
$1.32B
| $3.1M | ﹤0.01% |
647,488
+34,257
| +6% | +$221K |
|
|
NVTA
2884
DELISTED
Invitae Corporation
NVTA
| $3.1M | ﹤0.01% |
5,124,199
+312,304
| +6% | +$325K |
|
2885
EverQuote
EVER
$834M
| $3.09M | ﹤0.01% |
427,328
+17,992
| +4% | +$117K |
|
|
SSBK
2886
DELISTED
Southern States Bancshares
SSBK
| $3.08M | ﹤0.01% |
136,351
+1,469
| +1% | +$33.8K |
|
2887
Sigma Lithium
SGML
$1.18B
| $3.08M | ﹤0.01% |
94,911
+2,329
| +3% | +$83.3K |
|
2888
Quad
QUAD
$529M
| $3.07M | ﹤0.01% |
611,242
+8,564
| +1% | +$44.9K |
|
2889
Atara Biotherapeutics
ATRA
$76.9M
| $3.07M | ﹤0.01% |
83,063
+1,801
| +2% | +$80.2K |
|
2890
UroGen Pharma
URGN
$2.26B
| $3.07M | ﹤0.01% |
219,127
+17,406
| +9% | +$279K |
|
|
SRTA
2891
Strata Critical Medical Inc
SRTA
$506M
| $3.07M | ﹤0.01% |
1,184,928
+70,671
| +6% | +$248K |
|
2892
Karyopharm Therapeutics
KPTI
$43.3M
| $3.07M | ﹤0.01% |
152,476
+10,003
| +7% | +$224K |
|
2893
American Coastal Insurance
ACIC
$531M
| $3.04M | ﹤0.01% |
413,453
+10,804
| +3% | +$69.9K |
|
|
TTSH
2894
DELISTED
Tile Shop Holdings
TTSH
| $3.04M | ﹤0.01% |
553,649
-21,128
| -4% | -$122K |
|
|
GRTS
2895
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $3.04M | ﹤0.01% |
1,767,099
+91,041
| +5% | +$162K |
|
|
KG
2896
Kestrel Group
KG
$68.9M
| $3.04M | ﹤0.01% |
86,302
-1,098
| -1% | -$40.8K |
|
2897
PDS Biotechnology
PDSB
$40.6M
| $3.04M | ﹤0.01% |
601,360
+23,966
| +4% | +$131K |
|
2898
ARS Pharmaceuticals
SPRY
$532M
| $3.04M | ﹤0.01% |
803,341
+149,746
| +23% | +$983K |
|
2899
Atlanticus Holdings
ATLC
$1.68B
| $3.02M | ﹤0.01% |
99,692
+2,360
| +2% | +$85K |
|
2900
LCNB Corp
LCNB
$281M
| $3.02M | ﹤0.01% |
211,590
-836
| -0.4% | -$13.1K |
|
Similar funds
Geode Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
- Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
- Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
- Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
- Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
- Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
- Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.